Ashton Thomas Securities’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Ashton Thomas Securities’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.21K	Sell	44 -11	-20%	-$1.19K	﹤0.01%	369
2026 Q1	$5.71K	Hold	55	–	–	﹤0.01%	427
2025 Q4	$5.75K	Hold	55	–	–	﹤0.01%	289
2025 Q3	$5.09K	Hold	55	–	–	﹤0.01%	386
2025 Q2	$4.39K	Hold	55	–	–	﹤0.01%	274
2025 Q1	$4.76K	Hold	55	–	–	﹤0.01%	254
2024 Q4	$4.54K	Hold	55	–	–	﹤0.01%	251
2024 Q3	$4.78K	Buy	+55	New	+$4.71K	﹤0.01%	950

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Ashton Thomas Securities's PJP Position: Q2 2026 in Review

Ashton Thomas Securities reduced its Invesco Pharmaceuticals ETF (PJP) stake by 20% in Q2 2026, selling an estimated $1.19K and leaving 44 shares worth $5.21K. The position accounts for ﹤0.01% of the portfolio, ranked #369.

Ashton Thomas Securities first reported a position in PJP in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.75K in Q4 2025. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Ashton Thomas Securities held 44 shares of Invesco Pharmaceuticals ETF worth $5.21K as of Q2 2026.
Ashton Thomas Securities sold 11 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $1.19K.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Ashton Thomas Securities's portfolio in Q2 2026, its #369 holding.
Ashton Thomas Securities first reported a position in Invesco Pharmaceuticals ETF in Q3 2024 and has held it in 8 quarters since.
Ashton Thomas Securities's Invesco Pharmaceuticals ETF position peaked at $5.75K in Q4 2025.
117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Ashton Thomas Securities's 13F filing for Q2 2026, filed 27 Jul 2026.